News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
258,420 Results
Type
Article (14209)
Company Profile (22)
Press Release (244186)
Multimedia
Podcasts (26)
Webinars (3)
Section
Business (71781)
Career Advice (1125)
Deals (14572)
Drug Delivery (56)
Drug Development (34795)
Employer Resources (47)
FDA (6702)
Job Trends (5849)
News (126148)
Policy (10373)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
Academia (798)
Accelerated approval (29)
ADA (41)
Adcomms (8)
Allergies (111)
Alliances (11306)
ALS (132)
Alzheimer's disease (777)
Antibody-drug conjugate (ADC) (342)
Approvals (7236)
Artificial intelligence (397)
ASCO (221)
Autoimmune disease (206)
Automation (33)
Bankruptcy (111)
Best Places to Work (4938)
BIO (31)
BIOSECURE Act (4)
Biosimilars (156)
Biotechnology (21)
Bladder cancer (171)
Brain cancer (44)
Breast cancer (544)
Cancer (4041)
Cardiovascular disease (321)
Career advice (905)
Career pathing (13)
CAR-T (178)
CDC (14)
Celiac Disease (1)
Cell therapy (513)
Cervical cancer (38)
Clinical research (33455)
Collaboration (1203)
Company closure (1)
Compensation (675)
Complete response letters (28)
COVID-19 (1076)
CRISPR (61)
C-suite (499)
Cystic fibrosis (71)
Data (5874)
Decentralized trials (1)
Depression (114)
Dermatology (67)
Diabetes (400)
Diagnostics (2668)
Digital health (25)
Diversity (1)
Diversity, equity & inclusion (13)
Drug discovery (197)
Drug pricing (78)
Drug shortages (13)
Duchenne muscular dystrophy (190)
Earnings (55224)
Editorial (23)
Employer branding (10)
Employer resources (44)
Events (38101)
Executive appointments (522)
FDA (9163)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (11)
Frontotemporal dementia (25)
Funding (1065)
Gene editing (134)
Generative AI (27)
Gene therapy (411)
GLP-1 (701)
Government (1628)
Grass and pollen (5)
Guidances (379)
Healthcare (6988)
Hematology (106)
HIV (59)
Huntington's disease (31)
IgA nephropathy (75)
Immunology and inflammation (172)
Immuno-oncology (64)
Indications (146)
Infectious disease (1302)
Inflammatory bowel disease (111)
Inflation Reduction Act (6)
Influenza (105)
Intellectual property (122)
Interviews (199)
IPO (8557)
IRA (11)
Job creations (1193)
Job search strategy (776)
JPM (34)
Kidney cancer (19)
Labor market (55)
Layoffs (218)
Leadership (15)
Legal (2120)
Liver cancer (61)
Longevity (10)
Lung cancer (589)
Lymphoma (349)
Machine learning (35)
Management (11)
Manufacturing (522)
Marketing (2)
MASH (130)
Medical device (5173)
Medtech (5265)
Mergers & acquisitions (6843)
Metabolic disorders (1030)
mRNA (104)
Multiple sclerosis (120)
NASH (11)
Neurodegenerative disease (268)
Neuropsychiatric disorders (78)
Neuroscience (1734)
NextGen: Class of 2026 (2074)
Non-profit (1557)
Now hiring (41)
Obesity (496)
Opinion (87)
Ovarian cancer (136)
Pain (141)
Pancreatic cancer (191)
Parkinson's disease (236)
Partnered (13)
Patents (245)
Patient recruitment (368)
Peanut (38)
People (9540)
Pharmaceutical (12)
Pharmacy benefit managers (12)
Phase 1 (9054)
Phase 2 (14454)
Phase 3 (12762)
Pipeline (6903)
Policy (78)
Postmarket research (1214)
Preclinical (3147)
Press Release (15)
Prostate cancer (227)
Psychedelics (26)
Radiopharmaceuticals (151)
Rare diseases (666)
Real estate (1361)
Recruiting (20)
Regulatory (9648)
Reports (27)
Research institute (840)
Resumes & cover letters (209)
Rett syndrome (42)
RNA editing (11)
RSV (62)
Schizophrenia (119)
Series A (166)
Series B (131)
Service/supplier (3)
Sickle cell disease (67)
Special edition (14)
Spinal muscular atrophy (100)
Sponsored (16)
Startups (1171)
State (1)
Stomach cancer (7)
Supply chain (67)
Tariffs (31)
The Weekly (25)
Vaccines (576)
Venture capital (59)
Weight loss (344)
Women's health (67)
Worklife (10)
Date
Today (23)
Last 7 days (192)
Last 30 days (1123)
Last 365 days (17857)
2026 (9507)
2025 (18206)
2024 (16896)
2023 (16186)
2022 (20645)
2021 (20270)
2020 (19027)
2019 (16792)
2018 (12749)
2017 (11970)
2016 (10565)
2015 (12717)
2014 (9228)
2013 (7262)
2012 (7941)
2011 (8061)
2010 (7267)
Location
Africa (325)
Alabama (32)
Alaska (2)
Arizona (114)
Arkansas (6)
Asia (16655)
Australia (2533)
California (8287)
Canada (2175)
China (899)
Colorado (332)
Connecticut (412)
Delaware (306)
Europe (37374)
Florida (998)
Georgia (214)
Hawaii (3)
Idaho (19)
Illinois (680)
India (51)
Indiana (351)
Iowa (12)
Japan (455)
Kansas (59)
Kentucky (20)
Louisiana (39)
Maine (51)
Maryland (847)
Massachusetts (5859)
Michigan (143)
Minnesota (357)
Mississippi (5)
Missouri (85)
Montana (9)
Nebraska (8)
Nevada (84)
New Hampshire (34)
New Jersey (2355)
New Mexico (11)
New York (2045)
North Carolina (889)
North Dakota (4)
Northern California (4238)
Ohio (200)
Oklahoma (8)
Oregon (13)
Pennsylvania (1368)
Puerto Rico (15)
Rhode Island (20)
South America (475)
South Carolina (24)
Southern California (3229)
Tennessee (116)
Texas (1325)
United States (27964)
Utah (170)
Vermont (1)
Virginia (207)
Washington D.C. (33)
Washington State (700)
West Virginia (3)
Wisconsin (120)
Wyoming (2)
258,420 Results for "5".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Akari Therapeutics Announces $5.5 Million Private Placement Offering
May 21, 2026
·
7 min read
Press Releases
Opus Genetics Announces FDA Alignment on Phase 3 Registrational Trial Design for OPGx-LCA5 in LCA5-Associated Inherited Retinal Disease
July 6, 2026
·
6 min read
Drug Development
5 molecular glues that could stick—and the companies stuck in
Molecular glue degraders are gaining traction in the clinic as well as funding from Big Pharma, with their potential to treat previously “undruggable” cancers and immunological diseases. Here are five clinical programs worth keeping an eye on.
July 6, 2026
·
6 min read
·
Michael Gibney
Press Releases
Propanc Biopharma Initiates $5.0 Million Share Repurchase Program
July 2, 2026
·
3 min read
Press Releases
Medline to report second quarter 2026 results on August 5, 2026
July 1, 2026
·
1 min read
Press Releases
Nexus Pharmaceuticals Launches Cyclophosphamide Injection, 2.5 mL and 5 mL
April 7, 2026
·
1 min read
Career Advice
Putting the wrong foot forward: 5 tricky interview questions
Even something as simple as “Tell me about yourself” can trip up biopharma professionals during job interviews. Two recruiting experts discuss what candidates should and shouldn’t say when answering five specific questions.
June 17, 2026
·
5 min read
·
Angela Gabriel
Press Releases
Insulet to Announce Second Quarter 2026 Financial Results on August 5, 2026
July 1, 2026
·
1 min read
Press Releases
PlaqueTec Closes $5 Million Financing
April 27, 2026
·
2 min read
C-suite
The top 5 highest paid pharma CEOs in 2025
From Eli Lilly’s David Ricks to Pfizer’s Albert Bourla, the top five highest paid CEOs made a combined $157.8 million in 2025.
May 27, 2026
·
7 min read
·
Annalee Armstrong
1 of 25,842
Next
